Subsequently, the KI67expression was verified by immunohistochemistry, and the KI67expression level was found to be significantly reduced in the IPO5 gene silencing group (P < 0.01) (Figure 9(b)), suggesting IPO5 had an accelerating effect on esophageal cancer development. This evidence concerns the gene IPO5 and esophageal cancer.